RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses

- Hayman, Thomas J., Hsu, Alan C., Wark, Peter A., Kedzierska, Katherine, Masters, Seth L., Belz, Gabrielle T., Binder, Marco, Hansbro, Philip M., Nicola, Nicos A., Nicholson, Sandra E., Kolesnik, Tatiana B., Dagley, Laura F., Willemsen, Joschka, Tate, Michelle D., Baker, Paul J., Kershaw, Nadia J., Kedzierski, Lukasz, Webb, Andrew I.

Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ.

- Stifter, Sebastian A., Matthews, Antony Y., Mangan, Niamh E., Fung, Ka Yee, Drew, Alexander, Tate, Michelle D., Soares da Costa, Tatiana P., Hampsey, Daniel, Mayall, Jemma, Hansbro, Phil M., Garcia Minambres, Albert, Eid, Sahar G., Mak, Johnson, Scoble, Judy, Lovrecz, George, deWeerd, Nicole A., Hertzog, Paul J.

Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling

- Kedzierski, Lukasz, Tate, Michelle D., Bird, Nicola L., Chatfield, Simon M., Babon, Jeffrey J., Huntington, Nicholas, Belz, Gabrielle, Webb, Andrew, Wark, Peter A. B., Nicola, Nicos A., Xu, Jianqing, Kedzierska, Katherine, Hsu, Alan C., Hansbro, Philip M., Nicholson, Sandra E., Kolesnik, Tatiana B., Linossi, Edmond M., Dagley, Laura, Dong, Zhaoguang, Freeman, Sarah, Infusini, Giuseppe, Starkey, Malcolm R.